A New Blood based Test Predicts Response to Immune Checkpoint Inhibitors” - Kimmerling and Watson

Описание: “One of the big challenges when thinking about cancer is often this idea that within a tumor there's a lot of variability of every cell that's in that compact tumor. So a big challenge with therapies often is that a drug might only kill a few of those cells, not all the cells. For our version of testing, we take that tumor and break it down to all of its components, those single cells, those individual actors, and we're trying to test those cells to see which ones respond to therapies. That same concept of directly measuring individual cells can be applied to the immune system as well.

See the entire session:    • New Blood based Test which Predicts Respon...  

Rob Kimmerling, PhD, Co-Founder and their Chief Technical Officer at Travera, and Dennis Watson, Vice President of Business Development at Travera, are uniquely qualified to discuss ways you can personalize your immune checkpoint inhibitor treatments by predicting your likelihood of a positive response. Rob started in a lab at MIT where Travera’s unique weighing technology was developed for “functional testing”. Dennis has been working in genetics and genomics of cancer for nearly 20 years. Travera’s new immune system test is built on a novel advanced technology that analyzes the immune cells in your bloodstream to personalize treatment. It’s the first CLIA-approved test assessing baseline immune cell fitness, which can provide insight on your immune system's readiness for activation, while also functionally measuring which of the most commonly used immune checkpoint inhibitor drugs will do the best job of activating your immune cells.

The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are not intended as health care recommendations or medical advice by Cancer Patient Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health.